Here, we report on the isolation of a new class of highly specific human ADAM8 mAbs that bind to sequences within its DI, inhibit both its MP and DI activities, and demonstrate substantial in vivo anti-cancer efficacy. The gene discussed is ADAM8; the disease is cancer.